China Biologic Receives SFDA Approval For Clinical Trials Of FVIII
Sep 22nd, 2008 | By Editor | Category: NewsChina Biologic Products, a company producing plasma-based pharmaceuticals, has received approval from the Chinese State Food and Drug Administration to commence clinical trials of its new Human Coagulation Factor VIII product — a coagulation treatment for hemophilia and mass hemorrhaging.
China Biologic Products Gains Financial Support From Shandong Government
Jan 28th, 2008 | By Editorial Staff | Category: NewsChina Biologic Products, one of the leading manufacturers of plasma-based pharmaceutical products in China, has been granted a RMB1.5 million award by the Shandong Provincial Government for use in the improvement of its plasma production facilities in accordance with Shandong's "Double Hundred Project" initiative.
|
 
|
| |
|
